Tirzepatide, a novel drug , is generating considerable interest within the diabetes community. This dual-action compound, functioning as both a GLP-1 receptor for and a GIP agonist, demonstrates significant https://tirzepatide122997.veronicablog.com/64418916/tirzepatide-a-new-solution-for-type-2-diabetes-mellitus